Forum

Notifications

Clear all

Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Meta

Available Clinical Trials

1 Posts

1 Users

0 Reactions

1,116 Views

RSS

Charmaine Coimbra

(@motherblogger)

Posts: 14

Active Member

Topic starter

[#85]

Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer

This is an open clinical trial at the Mayo Clinic. Here is the link: https://www.mayo.edu/research/clinical-trials/cls-20440737

Posted : 21/05/2019 3:40 am

Forum Icons: Forum contains no unread posts Forum contains unread posts

Topic Icons: Not Replied Replied Active Hot Sticky Unapproved Solved Private Closed

(VELA) Study of BLU-222 in Advanced Solid Tumors | Identifier: NCT05252416

Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women With Recurrent Gynecologic Carcinosarcoma | Identifier: NCT05559879

Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma | Identifier: NCT05256225

Clinical trials are currently being offered at Medical University of South Carolina (MUSC) Health Care in Charleston SC. A Phase II/III Study of Paciltaxel/Carboplatin alone, or combined with either Trastuzumab… Read More »